1. 1174. Phase 2 STRIVE Clinical Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrates Consistent Trough Concentrations Across Diverse Patient Populations. (31st December 2020) Authors: Flanagan, Shawn; Rubino, Christopher M; Sandison, Taylor Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1284. Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin. (31st December 2020) Authors: Thompson, George R; Horcajada, Juan P; Locke, Jeffrey B; Viani, Rolando; Pappas, Peter; Ghannoum, Mahmoud; Sandison, Taylor; Soriano, Alex Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1286. Pharmacokinetics, Excretion, and Mass Balance of [14C]-Rezafungin Following Intravenous (IV) Administration in Healthy Adults. (31st December 2020) Authors: Ong, Voon; Flanagan, Shawn; Sandison, Taylor; Wills, Sarah Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1390. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Rezafungin (RZF) Dose Selection in Treatment of Candida. (26th November 2018) Authors: Lakota, Elizabeth A; Ganesan, Harish; Flanagan, Shawn; Ong, Voon; Sandison, Taylor; Bhavnani, Sujata M; Rubino, Christopher M; Ambrose, Paul G Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1694. Coadministration of Rezafungin Does Not Impact the Pharmacokinetics of Cyclosporine, Ibrutinib, Mycophenolate Mofetil, or Venetoclax. (15th December 2022) Authors: Flanagan, Shawn; Walker, Helen E; Ong, Voon; Director, Executive; Sandison, Taylor Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study. (26th November 2018) Authors: Thompson, George R; Vazquez, Jose; Soriano, Alex; Skoutelis, Athanasios; Ostrosky-Zeichner, Luis; Mena, Karen; Navalta, Laura; Sandison, Taylor; Pappas, Peter Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis. (15th December 2022) Authors: Thompson, George R; Soriano, Alex; Cornely, Oliver A; Kullberg, Bart-Jan; Kollef, Marin; Vazquez, Jose A; Das, Anita F; Locke, Jeffrey B; Sandison, Taylor; Pappas, Peter G Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2389. Effect of Rezafungin on QT Interval in Healthy Subjects. (26th November 2018) Authors: Flanagan, Shawn; Goodman, Daniel B; Rao, Pallavi; Jandourek, Alena; O'Reilly, Terry; Sandison, Taylor Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 262Effect of NSAID/Corticosteroid Use on the Efficacy of Tedizolid in Acute Bacterial Skin and Skin Structure Infections: Pooled Data From the Phase 3 ESTABLISH-1 and ESTABLISH-2 Studies. (December 2014) Authors: Sandison, Taylor; De Anda, Carisa; Das, Anita; Prokocimer, Philippe Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 268Clinical Response of Tedizolid vs Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure: Pooled Analysis of 2 Phase 3 Double-Blind Trials. (December 2014) Authors: Sandison, Taylor; De Anda, Carisa; Fang, Edward; Das, Anita; Prokocimer, Philippe Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗